{
    "organizations": [],
    "uuid": "7714b2c7986fee52c4630e44b95ba69147c70c91",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-tianjin-zhongxin-pharmaceutical-gr/brief-tianjin-zhongxin-pharmaceutical-group-corp-posts-q1-profit-of-rmb174-1-mln-idUSFWN1S40O7",
    "ord_in_thread": 0,
    "title": "BRIEF-Tianjin Zhongxin Pharmaceutical Group Corp Posts Q1 Profit Of RMB174.1 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 27 (Reuters) - Tianjin Zhongxin Pharmaceutical Group Corp Ltd:\n* QTRLY PROFIT, NET OF TAX RMB174.1 MILLION VERSUS RMB133.3 MILLION\n* Q1 REVENUE RMB1.62 BILLION VERSUS RMB1.48 BILLION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-27T18:28:00.000+03:00",
    "crawled": "2018-04-28T12:28:22.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "tianjin",
        "zhongxin",
        "pharmaceutical",
        "group",
        "corp",
        "ltd",
        "qtrly",
        "profit",
        "net",
        "tax",
        "million",
        "versus",
        "million",
        "q1",
        "revenue",
        "billion",
        "versus",
        "billion",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}